Toyota (TM) Dec. U.S. Sales Rose 9%, Est. Up 10%
- Stock futures flat as investors fathom Fed comments on rates
- Mylan (MYL) Plans to Launch Generic EpiPen; Will Cost 50% Less than Name Brand
- Dollar hits 3-week high vs yen as U.S. rate rise signals get louder
- Mylan's (MYL) Epipen4Schools Program is a Complicated Maze of Specialty Distribution Cos - Wells Fargo's Maris
- Carl Icahn Bought 2.3M Herbalife (HLF) Shares Friday, Rips Bill Ackman
Toyota Motor Corp. (NYSE: TM) December sales rose 9 percent, estimated to be up 10 percent.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Mexican Adventure for Toyota GAZOO Racing
- Dollar Tree (DLTR) Misses Q2 EPS by 1c; Updates FY16 Outlook
- Toyota Motor Sales Opens New Lexus Parts Distribution Center in Atlanta
Create E-mail Alert Related CategoriesRetail Sales
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!